Opinion|Videos|May 18, 2026

Psychosocial Impacts and Traditional Treatment Modalities in Vitiligo

In this episode, ‘Psychosocial Impacts and Traditional Treatment Modalities in Vitiligo,’ the expert dermatologist explored the following questions:

In this episode, ‘Psychosocial Impacts and Traditional Treatment Modalities in Vitiligo,’ the expert dermatologist explored the following questions:


What are the psychosocial impacts that are commonly experienced by patients living with vitiligo?


Which options have been traditionally used to manage vitiligo and do they still have a role in clinical practice today?


The panelists examined the profound psychosocial and cultural burdens associated with vitiligo, noting extreme cases where the disease has led to cancelled weddings or requests for limb amputation. While the condition is often physically asymptomatic, patients face increased rates of anxiety and depression and may change their habits to avoid sunlight, which enhances the contrast of depigmented skin. David Rosmarin explained that traditional management relies on topical corticosteroids (TCS), calcineurin inhibitors (TCIs), and phototherapy to calm the immune system and stimulate melanocytes. These treatments remain in clinical practice today, though they are often used in combination to maximize efficacy while minimizing side effects like skin atrophy.


Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.


The next episode in this series, ‘A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends,’ features the panelists advancing their conversation on vitiligo (vitiligo) and focusing on the clinical data from the TRu-V phase 3 program and the long-term repigmentation results observed with ruxolitinib cream.


Latest CME